Abstract:Background Individuals with CKD may be at high risk for atherosclerotic cardiovascular disease (ASCVD). However, there are no ASCVD risk prediction models developed in CKD populations to inform clinical care and prevention. Methods We developed and validated 10-year ASCVD risk prediction models in patients with CKD that included participants without self-reported cardiovascular disease from the Chronic Renal Insufficiency Cohort (CRIC) study. ASCVD was defined as the first occurrence of adjudicated fatal and nonfatal stroke or myocardial infarction. Our models used clinically available variables and novel biomarkers. Model performance was evaluated based on discrimination, calibration, and net reclassification improvement. Results Of 2604 participants (mean age 55.8 years; 52.0% male) included in the analyses, 252 had incident ASCVD within 10 years of baseline. Compared with the American College of Cardiology/American Heart Association pooled cohort equations (area under the receiver operating characteristic curve [AUC]=0.730), a model with coefficients estimated within the CRIC sample had higher discrimination ( P =0.03), achieving an AUC of 0.736 (95% confidence interval [CI], 0.649 to 0.826). The CRIC model developed using clinically available variables had an AUC of 0.760 (95% CI, 0.678 to 0.851). The CRIC biomarker-enriched model had an AUC of 0.771 (95% CI, 0.674 to 0.853), which was significantly higher than the clinical model ( P =0.001). Both the clinical and biomarker-enriched models were well-calibrated and improved reclassification of nonevents compared with the pooled cohort equations (6.6%; 95% CI, 3.7% to 9.6% and 10.0%; 95% CI, 6.8% to 13.3%, respectively). Conclusions The 10-year ASCVD risk prediction models developed in patients with CKD, including novel kidney and cardiac biomarkers, performed better than equations developed for the general population using only traditional risk factors. Significance Statement Patients with CKD are typically considered to be at high risk for atherosclerotic cardiovascular disease, but CKD is a heterogeneous condition and there are no validated atherosclerotic cardiovascular disease risk stratification tools for this population. Our analysis of 2604 participants in the Chronic Renal Insufficiency Cohort study found that newly developed risk prediction models, using clinically available variables and novel biomarkers, improved discrimination, calibration, and reclassification of nonevents compared with the traditional American College of Cardiology/American Heart Association pooled cohort equations developed for the general population. The new equations may improve risk stratification in patients with CKD and improve shared decision making for preventive therapy to reduce atherosclerotic cardiovascular disease incidence and mortality. Visual

The Cardiovascular Literature-Based Risk Algorithm (CALIBRA): Predicting Cardiovascular Events in Patients With Non-Dialysis Dependent Chronic Kidney Disease

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Incorporating Kidney Disease Measures into Cardiovascular Risk Prediction: Development and Validation in 9 Million Adults from 72 Datasets.

Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study

A 4-Variable Model to Predict Cardio-Kidney Events and Mortality in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic Review

Computational and Human Intelligence Methods for Constructing Practical Risk Prediction Models: An Application to Cardio-Renal Outcomes in Non-Diabetic CKD Patients

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial

Machine learning model for cardiovascular disease prediction in patients with chronic kidney disease

Development of an accessible 10-year Digital CArdioVAscular (DiCAVA) risk assessment: a UK Biobank study

Development of Risk Prediction Equations for Incident Chronic Kidney Disease

The CMLA Score: A Novel Tool for Early Prediction of Renal Replacement Therapy in Patients with Cardiogenic Shock

The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients

Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study

Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers

Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project

Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD

Cardiovascular Risk Models in Chronic Kidney Disease: A Systematic Review and External Validation of Models

Prediction of incident chronic kidney disease in community-based electronic health records: a systematic review and meta-analysis